TRIM24 targets p53 degradation,21 a molecule recently reported to play a role in clinical immunity, as p53 is upregulated at RNA and protein level in asymptomatic P. falciparum carriers during the malaria season in Mali.19 The gene discussed is TP53; the disease is malaria.